Associate Professor
Program Director, Hematology & Medical Oncology Fellowship
Division of Hematology and Oncology
Initiatives include evaluation of mechanisms designed to lessen drug resistance in patients on cancer chemotherapy. In the field of breast cancer, projects are underway to evaluate the impact of treatment on sexuality and the physical changes that occur among women who participate in an exercise program following chemotherapy.
Breast Cancer Risk Reduction, Breast Cancer Treatment, Head and Neck Cancer
Medical School
University of Tennessee, Memphis, 1983
Residency
Internal Medicine, University of Massachusetts in Worchester Memorial Hospital, Massachusetts, 1986
Fellowship
Hematology/Oncology, Duke University Medical Center, North Carolina, 1989
Internal Medicine
Medical Oncology
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
Alsharif O, Panella T, Nodit L, Hu MI.
Letter to the editor: ETV6-NTRK2 fusion identified in a patient with medullary thyroid carcinoma. Thyroid. 2023 Apr 24. doi: 10.1089/thy.2022.0630. Online ahead of print.
Alsharif O, Panella T, Nodit L, Hu MI.
ETV6-NTRK2 fusion identified in a patient with medullary thyroid carcinoma. Thyroid. 2023 Mar 24. doi: 10.1089/thy.2022.0630. Online ahead of print.
The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290
Copyright © 2023